Provider reported barriers and solutions to improve testing among tuberculosis patients 鈥榚ligible for drug susceptibility test'
A qualitative study from programmatic setting in India
Abstract
In a study conducted in Bhopal district (a setting with facility for molecular drug susceptibility testing (DST)) located in central India in 2014鈥�15, we found high levels of pre-diagnosis attrition among patients with presumptive multi drug-resistant tuberculosis (MDR-TB)鈥搈eaning TB patients who were eligible for DST, were not being tested.
In this study, we explored the health care provider perspectives into barriers and suggested solutions for improving DST.
This research was supported by the UK Department for International Development鈥檚 Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Citation
Shewade HD, Kokane AM, Singh AR, Parmar M, Verma M, Desikan P, Khan SN, Kumar AM V. Provider reported barriers and solutions to improve testing among tuberculosis patients 鈥渆ligible for drug susceptibility test鈥�: A qualitative study from programmatic setting in India. Escobar-Guti茅rrez A, editor. PLoS One [Internet]. Public Library of Science; 2018 Apr 20 [cited 2018 Jun 25];13(4):e0196162. Available from: http://dx.plos.org/10.1371/journal.pone.0196162